{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Esperion Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"ESPR"},"Address":{"label":"Address","value":"3891 RANCHERO DRIVE,SUITE 150, ANN ARBOR, Michigan, 48108, United States"},"Phone":{"label":"Phone","value":"+1 734 887-3903"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment."},"CompanyUrl":{"label":"Company Url","value":"https://www.esperion.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Glenn Brame","title":"Chief Technical Operations Officer"},{"name":"Sheldon L. Koenig","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}